SCHEMBL1691901

SCHEMBL1691901

O=c1c(Cl)c(Cl)cnn1Cc1ccccc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 13/20 0.71
▸ ALDH1A1 P00352 12/20 0.71
▸ NPSR1 Q6W5P4 8/20 0.71
▸ RAB9A P51151 8/20 0.71
▸ SMN1; SMN2 Q16637 6/20 0.71
▸ POLB P06746 5/20 0.71
▸ MITF O75030 4/20 0.71
▸ MEN1 O00255 3/20 0.71
▸ KMT2A Q03164 3/20 0.71
▸ PKM P14618 2/20 0.71
▸ BLM P54132 1/20 0.71
▸ GPR35 Q9HC97 1/20 0.71
▸ LMNA P02545 6/20 0.71
▸ CYP1A2 P05177 1/20 0.71
▸ CYP3A4 P08684 1/20 0.71
▸ CYP2C19 P33261 1/20 0.71
▸ MAPT P10636 10/20 0.65
▸ RECQL P46063 2/20 0.65
▸ NPC1 O15118 5/20 0.60
▸ S1PR4 O95977 3/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19000706 0.86 HTT (0.77) HTTALDH1A1NPSR1RAB9ASMN1; SMN2
SCHEMBL19011761 0.84 HTT (0.71) HTTALDH1A1NPSR1RAB9ASMN1; SMN2
SCHEMBL12218257 0.84 HTT (1.00) HTTALDH1A1NPSR1RAB9ASMN1; SMN2
SCHEMBL19011793 0.84 HTT (0.71) HTTALDH1A1NPSR1RAB9ASMN1; SMN2
SCHEMBL25341629 0.83 NPBWR1 (0.60) HTTALDH1A1NPSR1RAB9ASMN1; SMN2
SCHEMBL31174056 0.83 HTT (0.59) HTTALDH1A1NPSR1RAB9ASMN1; SMN2
SCHEMBL8963991 0.83 HTT (0.59) HTTALDH1A1NPSR1RAB9ASMN1; SMN2
SCHEMBL22989953 0.83 ALDH1A1 (0.52) HTTALDH1A1NPSR1RAB9ASMN1; SMN2
SCHEMBL9123380 0.83 HTT (0.72) HTTALDH1A1NPSR1RAB9ASMN1; SMN2
SCHEMBL10642561 0.83 RAB9A (1.00) HTTALDH1A1NPSR1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0645964-A1 HERBICIDAL COMPOSITION. DOWELANCO (US) 1995-04-05 — — EP claimed
WO-1994023578-A1 HERBICIDAL COMPOSITION DOWELANCO (US) 1994-10-27 — — WO claimed
JP-6001773-A — — None — — JP disclosed
JP-6001772-A — — None — — JP disclosed
EP-4737457-A1 POLYSUBSTITUTED MACROCYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF Shenzhen Salubris Pharmaceuticals Co., Ltd. (CN) 2026-05-06 — — EP disclosed
US-20250154139-A1 PYRIDAZINONE COMPOUNDS AS TRPA1 INHIBITORS D. E. SHAW RESEARCH, LLC 2025-05-15 — — US disclosed
CN-119894901-A Polysubstituted macrocyclic compound, and preparation method and application thereof 深圳信立泰药业股份有限公司 2025-04-25 — — CN disclosed
WO-2025002297-A1 POLYSUBSTITUTED MACROCYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF 深圳信立泰药业股份有限公司 2025-01-02 — — WO disclosed
EP-4472624-A2 PYRIDAZINONE COMPOUNDS AS TRPA1 INHIBITORS D.E. Shaw Research, LLC (US) 2024-12-11 — — EP disclosed
CN-118973564-A Pyridazinone compounds as TRPA1 inhibitors D·E·萧尔研究有限责任公司 2024-11-15 — — CN disclosed
CN-118852163-A Macrocyclic compound containing heteroatoms, and preparation method and application thereof 深圳信立泰药业股份有限公司 2024-10-29 — — CN disclosed
EP-0201765-B1 3(2H)PYRIDAZINONE, PROCESS FOR ITS PREPARATION AND ANTI-ALLERGIC AGENT CONTAINING IT NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1991-09-18 — — EP disclosed
EP-0398293-A1 Pyridazinone derivatives and compositions for controlling and/or preventing insect pests NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1990-11-22 — — EP disclosed
US-4892947-A 3(2H)Pyridazinone, process for its preparation and anti-allergic agent containing it NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1990-01-09 — — US disclosed
EP-0258391-A1 USE OF HETEROCYCLIC NITROGEN-CONTAINING COMPOUNDS FOR REDUCING MOISTURE LOSS FROM PLANTS AND INCREASING CROP YIELD RHONE POULENC NEDERLAND B.V. (NL) 1988-03-09 — — EP disclosed
WO-1987004321-A2 USE OF HETEROCYCLIC NITROGEN-CONTAINING COMPOUNDS FOR REDUCING MOISTURE LOSS FROM PLANTS AND INCREASING CROP YIELD RHONE-POULENC NEDERLANDS B.V. (NL) 1987-07-30 — — WO disclosed
EP-0201765-A2 3(2H)Pyridazinone, process for its preparation and anti-allergic agent containing it NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1986-11-20 — — EP disclosed
EP-0014562-B1 PYRIDAZINES FOR USE IN TREATING FUNGAL INFECTIONS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESSES FOR THEIR PREPARATION Pfizer Limited (GB) 1983-10-05 — — EP disclosed
EP-0014562-A1 Pyridazines for use in treating fungal infections, pharmaceutical compositions containing them, and processes for their preparation Pfizer Limited (GB) 1980-08-20 — — EP disclosed
US-4002751-A SLEEP INDUCERS, CNS DEPRESSANTS SANDOZ, INC. (US) 1977-01-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250154139-A1 PYRIDAZINONE COMPOUNDS AS TRPA1 INHIBITORS TRPA1, TRPV1, TRPV5 HTT 887/4885ALDH1A1 538/4885NPSR1 412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback